Member Info for themuir01

Proprietary programme IND submission Phase I trial
AVA6000 (pro-doxorubicin) Q2 2020 H2 2020
AVA004 (monotherapy – PD-L1 inhibitor) Q4 2020 H1 2021
AVA004/100 (TMAC molecule) H2 2021 H1 2022
AVA021 (bispecific therapy – PD-L1 & LAG-3 inhibitors) 2022 2022

AVA6000 Phase I trial is fully funded out of the Company’s existing cash resources.
- If the AVA6000 trial is successful, management believes that it will be in a position to secure a licensing deal
for the drug before end 2020. This would include upfront and near-term (within 12 months) milestone
payments of something in the region of $50m.
- This sum would be sufficient to cover all of the Company’s financing requirements until well into 2023,
including the three Phase I trials pencilled in for 2021 and 2022. By that stage we believe additional licensing
agreements would have been established, such that there is a reasonable possibility that Avacta would never
have to raise money again via the equity markets.
- A successful AVA6000 trial would likely fast-track other reformulated chemotherapies developed by the
pre|CISION platform – notably AVA3996, the FAP-activated proteasome inhibitor. We believe that it
could even leapfrog the intended AVA004 and AVA004/100 trials noted above, given the nearer term
opportunity for commercialisation.

Yes just below

https://aimchaos.files.wordpress.com/2020/03/avacta-group-investment-thesis-3.pdf

Hi Ken, have you managed to read Myles's PDF... has a lot of good information on it

Stop being Nosey Burland (",)

No one said results euclid55

No Jessell... only for the nosey ones trying to work out their worth :-)

Put it this way... it will be more than stated over the next few days.

GL to you Jessell.

No RK its a bit more than that now

Nice to have you here!

FRR.. god I bought into them a few years ago (lost a bit).,.. they've been delisted a while..

I hate it when people mention how much money they have or are spending... theres no need

RichKen 5k and 10k buys arent large....

It depends Shaf.. either will rise although we are in the early stages here.. if you are trading go for GDR... mid its had some wild swings too so be careful. Good luck which ever you decide.

I'm at just under 100,000 shares here... have a few others but mostly here now.

GE heathlcare 7000 staff... billions of revenue... sealed it for me

Watch for any new releases on NASDAQ... possible cancer trials... awaiting 2 announcements

GDR seem decent was in and out there... their redesign is looking good but you still need a machine onsite to test...but anything that helps pandemic the better I say... I need to get back to normality

https://privateharleystreetclinic.com/products/covid-19-test

And you have to wait 2 days... you'll be buying packs of 10 that give you result sin less than 10 mins soon enough...

....

Seeing this a lot on Twitter...

With all that data....why is this not 1p as predicted by the rampies?

All FOS.. just be careful guys, don't take much serious with whats posted. This is a voila tile share and swings massively but it always goes back up.

I sold out yesterday but will be back.. but like I said.. the £10, £20 brigade are all idiots.

The French do love a shake.